Different tools for estimating cardiovascular risk in Brazilian postmenopausal women

Gynecological Endocrinology

Volumn 29, Issue 10, 2013, Pages 921-925

  Nahas, Eliana A P ^a   Andrade, Aline M ^a   Jorge, Mayra C ^a   Orsatti, Claudio L ^a   Dias, Flavia B ^a   Nahas Neto, Jorge ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Cardiovascular disease; Framinghan risk score; Menopause; Metabolic syndrome

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AMENORRHEA; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; FEMALE; FRAMINGHAM RISK SCORE; GLUCOSE BLOOD LEVEL; HIGH RISK POPULATION; HUMAN; IMMOBILIZATION; LIPOPROTEIN BLOOD LEVEL; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MENOPAUSE; METABOLIC SYNDROME X; PHYSICAL ACTIVITY; POSTMENOPAUSE; PRIORITY JOURNAL; SMOKING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

AGED; BODY MASS INDEX; BRAZIL; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; DIAGNOSTIC TECHNIQUES, CARDIOVASCULAR; FEMALE; HUMANS; LIPIDS; METABOLIC SYNDROME X; MIDDLE AGED; POSTMENOPAUSE; RISK FACTORS; WAIST CIRCUMFERENCE;

EID: 84883567770     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2013.819084     Document Type: Article

References (30)

1. Mosca L, Banka CL, Benjamin EJ, et al. Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation 2007;115:1481-501.
2. Anand SS, Islam S, Rosengren A, et al. Risk factors for myocardial in women and men: insights from the INTERHEART study. Eur Heart J 2008;29:932-40.
3. Kannel WB, D'Agostino RB, Sullivan L, Wilson PWF. Concept and usefulness of cardiovascular risk profiles. Am Heart J 2004;148: 16-26.
4. Pe´rez-Lopez FR, Chedraui P, Gilbert JJ, Pe´rez- Roncero G. Cardiovascular risk in menopausal women and prevalent related co-morbid condition: facing the post-Women's Health Initiative era. Fertil Steril 2009;92:1171-86.
5. Yusuf S, Hawken S, O ̂ unpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52countries, Interheart study: case-control study. Lancet 2004;364:937-52.
6. Wilson PWF, D'Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97: 1837-47.
7. Schneider JG, Tompkins C, Blumenthal RS, Mora S. The metabolic syndrome in women. Cardiol Rev 2006;14:286-91.
8. Ford ES, Giles WH, Mokad AH. Increasing prevalence of the metabolic syndrome among US adults. Diabetes Care 2004;27: 2444-9.
9. Nahas EAP, Padoani NP, Nahas-Neto J, et al. Metabolic syndrome and its associated risk factors in Brazilian postmenopausal women. Climacteric 2009;12:431-8.
10. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
11. American Diabetes Association (ADA). Standards of Medical Care in Diabetes-2006. Diabetes Care 2006;29:S4-42.
12. Pelletier P, Lapointe A, Laflamme N, et al. Discordances among different tools used to estimate cardiovascular risk in postmenopausal women. Can J Cardiol 2009;5:e413-16.
13. Agrinier N, Cournot M, Dallongeville J, et al. Menopause and modifiable coronary heart disease risk factors: a population based study. Maturitas 2010;65:237-43.
14. Bittner V. Menopause, age, and cardiovascular risk-a complex relationship. J Am Coll Cardiol 2009;54:2374-5.
15. Lakoski SG, Greenland P, Wong ND, et al. Coronary artery calcium scores and risk for cardiovascular events in women classified as "low risk" based on Framingham risk score: The Multi-Ethnic Study of Atherosclerosis (MESA). Arch Intern Med 2007;167: 2437-42.
16. Lambrinoudaki I, Armeni E, Georgiopoulos G, et al. Subclinical atherosclerosis in menopausal women with low to medium calculated cardiovascular risk. Int J Cardiol 2013;164:70-6.
17. Guthrie JR, Dennerstein L, Taffe JR, Donnelly V. Health careseeking for menopausal problems. Climacteric 2003;6:112-7.
18. Matthews KA, Crawford SL, Chae CU, et al. Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition? J Am Coll Cardiol 2009;54:2366-73.
19. Yusuf S, Hawken S, O ̂ unpuu S, et al. Obesity and the risk of myocardial infarction in 27 000 participants from 52 countries; a case-control study. Lancet 2005;366:1640-9.
20. Ogden CL, Carroll MD, Cutin LR, et al. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006;295: 1549-55.
21. Zhang C, Rexrode KM, vanDam RM, et al. Abdominal obesity and the risk of all-cause, cardio-vascular, and cancer mortality, 16 years of follow-up in US women. Circulation 2008;117:1658-67.
22. Price GM, Uauy R, Breeze E, et al. Weight, shape, and mortality risk in older persons: elevated waist-hip ratio, not high body mass index, is associated with a greater risk of death. Am J Clin Nutrition 2006; 84:449-60.
23. Obunai K, Jani S, Dangas GD. Cardiovascular morbidity and mortality of the metabolic syndrome. Med Clin N Am 2007;91: 1169-84.
24. Kang HM, Kim DJ. Metabolic Syndrome versus Framingham risk score for association of self-reported coronary heart disease: the 2005 Korean health and nutrition examination survey. Diabetes Metab J 2012;36:237-44.
25. Lobo RA. Metabolic syndrome after menopause and the role of hormones. Maturitas 2008;60:10-8.
26. Ferrer J, Nevro JL, Estevez A. Identification of risk factors for prevention and early diagnosis of a-symptomatic post-menopausal women. Maturitas 2005;52:7-22.
27. Mosca L, Linfante AH, Benjamin EJ, et al. National study of physician awareness and adherence to cardiovascular disease prevention guidelines. Circulation 2005;111:499-510.
28. Mosca L, Merz NB, Blumenthal RS, et al. Opportunity for intervention to achieve American Heart Association guidelines for optimal lipid levels in high-risk women in a managed care setting. Circulation 2005;111:488-93.
29. Vajo Z, Acs N, Toth K, et al. Cardiovascular risk status and primary prevention in postmenopausal women: the MENOCARD study. Wien Klin Wochenschr 2009;121:202-8.
30. Sturdee DW and the Writing Group on behalf of the Workshop Consensus Group of International Menopause Society. Aging, menopause, cardiovascular disease and HRT. Climacteric 2009;12: 368-77.